Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer: a Randomized, Double Blind, Placebo-controlled Study.

NCT03055026 is registered in ClinicalTrials.gov with Fadoi Foundation, Italy as lead sponsor.

NCT NCT03055026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03055026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer: a Randomized, Double Blind, Placebo-controlled Study.
Lead sponsor
Fadoi Foundation, Italy
Phase
Phase 3
Overall status
Completed
Start date
May 3, 2017
Completion date
September 6, 2021
Enrollment
582 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

prevention of venous thromboembolism